The many faces of macrophage activation

Stein, 1992, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J. Exp. Med., 176, 287, 10.1084/jem.176.1.287

Modolell, 1995, Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines, Eur. J. Immunol., 25, 1101, 10.1002/eji.1830250436

Gratchev, 2001, Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3, Scand. J. Immunol., 53, 386, 10.1046/j.1365-3083.2001.00885.x

Gerber, 2001, Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors, J. Immunol., 166, 6861, 10.4049/jimmunol.166.11.6861

Anderson, 2002, A novel phenotype for activated macrophages: the type II activated macrophage, J. Leukoc. Biol, 72, 101, 10.1189/jlb.72.1.101

Anderson, 2002, Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors, J. Immunol., 168, 3697, 10.4049/jimmunol.168.8.3697

Nathan, 1991, Mechanisms and modulation of macrophage activation, Behring Inst. Mitt., 200

Hibbs, 2002, Infection and nitric oxide, J. Infect. Dis., 185, S9, 10.1086/338005

MacMicking, 1997, Nitric oxide and macrophage function, Annu. Rev. Immunol., 15, 323, 10.1146/annurev.immunol.15.1.323

Ehrt, 2001, Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase, J. Exp. Med., 194, 1123, 10.1084/jem.194.8.1123

Mosser, 1992, Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes, J. Leukoc. Biol., 52, 369, 10.1002/jlb.52.4.369

Ezekowitz, 1984, Alterations of surface properties by macrophage activation: expression of receptors for Fc and mannoseterminal glycoproteins and differentiation antigens, Contemp. Top. Immunobiol., 13, 33

Gruenheid, 2000, Genetic susceptibility to intracellular infections: Nramp1, macrophage function and divalent cations transport, Curr. Opin. Microbiol., 3, 43, 10.1016/S1369-5274(99)00049-1

Carlin, 1989, Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes, J. Leukoc. Biol., 45, 29, 10.1002/jlb.45.1.29

Dacosta, 1991, Association of lung carcinoma and tuberculosis, J. Postgrad. Med., 37, 185

Flavell, 2002, The relationship of inflammation and initiation of autoimmune disease: role of TNF super family members, Curr. Top. Microbiol. Immunol., 266, 1

Ho, 1994, Interleukin-10 and its receptor, Ther. Immunol., 1, 173

Reed, 1999, TGF-beta in infections and infectious diseases, Microbes Infect., 1, 1313, 10.1016/S1286-4579(99)00252-X

Morrison, 2002, Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages, J. Immunol., 168, 853, 10.4049/jimmunol.168.2.853

Huynh, 2002, Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation, J. Clin. Invest., 109, 41, 10.1172/JCI0211638

Nandan, 2000, Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis, J. Leukoc. Biol., 67, 464, 10.1002/jlb.67.4.464

Ting, 1999, Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1, J. Immunol., 163, 3898, 10.4049/jimmunol.163.7.3898

Goerdt, 1999, Other functions, other genes: alternative activation of antigen-presenting cells, Immunity, 10, 137, 10.1016/S1074-7613(00)80014-X

Rutschman, 2001, Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production, J. Immunol., 166, 2173, 10.4049/jimmunol.166.4.2173

Schebesch, 1997, Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro, Immunology, 92, 478, 10.1046/j.1365-2567.1997.00371.x

Goerdt, 1999, Alternative versus classical activation of macrophages, Pathobiology, 67, 222, 10.1159/000028096

Song, 2000, Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts, Cell. Immunol., 204, 19, 10.1006/cimm.2000.1687

Hesse, 2001, Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism, J. Immunol., 167, 6533, 10.4049/jimmunol.167.11.6533

Mills, 2000, M-1/M-2 macrophages and the Th1/Th2 paradigm, J. Immunol., 164, 6166, 10.4049/jimmunol.164.12.6166

Kodelja, 1998, Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern, J. Immunol., 160, 1411, 10.4049/jimmunol.160.3.1411

Raes, 2002, Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages, J. Leukoc. Biol., 71, 597, 10.1189/jlb.71.4.597

Sutterwala, 1997, Selective suppression of interleukin-12 induction after macrophage receptor ligation, J. Exp. Med., 185, 1977, 10.1084/jem.185.11.1977

Sutterwala, 1998, Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I, J. Exp. Med., 188, 217, 10.1084/jem.188.1.217